Chemoprevention and Barrett's Esophagus: Decisions, Decisions-Reference-Cited by-同舟云学术

Chemoprevention and Barrett's Esophagus: Decisions, Decisions

Published:2008-10 Issue:10 Volume:103 Page:2443-2445
ISSN:0002-9270
Container-title:The American Journal of Gastroenterology
language:en
Short-container-title:

Author:

Falk Gary W.,Jankowski Janusz

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference18 articles.

1. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence;Pohl;J Natl Cancer Inst,2005

2. Management of Barrett's oesophagus in the UK: Over treated, and under biopsied but improved by a national randomized trial;Das;Am J Gastroenterol,2008

3. 3. National Cancer Institute. Decline in cancer death rate accelerating. Available at: http://www.cancer.gov/ncicancerbulletin/nci_cancer_bulletin_102307. Accessed June 19, 2008.

4. Increasing incidence of Barrett's oesophagus in the general population;van Soest;Gut,2005

5. Mortality rates in patients with Barrett's oesophagus;Moayyedi;Aliment Pharmacol Ther,2008

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COX-2 strengthens the effects of acid and bile salts on human esophageal cells and Barrett esophageal cells;BMC Molecular and Cell Biology;2022-04-12

2. Barrett's Esophagus;The Esophagus;2021-04-30

3. Acid-suppressive Medications and Risk of Esophageal Adenocarcinoma in Patients With Barrett’s Esophagus(Gut 2014;63:1229-1237);Journal of Neurogastroenterology and Motility;2015-04-03

4. Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis;Gut;2013-11-12

5. Boxing Bladder Cancer with COX-2–specific Inhibition;Cancer Prevention Research;2011-09-06